CBD (at 0.5–7 μl/mL) inhibits the spheroid formation and dow-nregulates CB1 and CB2 receptors, VEGF, PSA, and pro-inflammatory cytokines IL-6/IL-8 in LNCaP prostate cancer stem cells [91]. Here, CNR1 is linked to Familial prostate cancer.